期刊文献+

冻干人纤维蛋白原质量提高的研究 被引量:6

Technology research on lyophilized human fibrinogen
下载PDF
导出
摘要 目的通过调整生产工艺和工艺参数来提高产品的质量。方法健康人血浆化浆后采用离心方法去除冷沉淀,然后进行8%低温乙醇反应获得FI沉淀。FI沉淀进行抽提溶解,过滤后上清进行S/D病毒灭活(0.3%磷酸三丁酯和1%的吐温80);灭活后制品再进行2次8%乙醇反应以去除S/D试剂同时对制品进一步纯化,最终获得F1-2沉淀;对F1-2沉淀进行抽提溶解,过滤后超滤透析浓缩,再进行配制、除菌过滤,分装、冻干;冻干结束进行100℃30 min干热病毒灭活。结果最终的制品的纯度提高了15%左右,外观和可见异物合格,同时收率提高了30%左右。结论用改进工艺后的工艺制备的冻干人纤维蛋白原的质量和收率都得到了提高。 Objective To improve the quality of the products by adjusting the process and parameters. Methods Centrifuge was used to remove the cold precipitates from plasma, and then ethanol was added to 8% concentration at a low temperature. FI precipitates were obtained. Precipitated F1 was dissolved by extraction buffer. Filtration began S/D virus inactivation (0. 3% tributyl phosphate and 1% of tween 80). Inactivated products removed S/D reagent by 8% ethanol reaction, and further purification products were obtained. In the end, precipitates F1-2 were obtained. Fibrinogen was extracted from F1-2 precipitates and filtrates. Later, the products underwent uhrafihration, enrichment, preparation, aseptic filtration, packing and freeze-dried method. After freeze-drying, the products began to inactivate virus with the dry-freeze method of 100 ℃ for 30 min. Results The purity of the products increased by 15%. The appearance and visible foreign matter were qualified. The yield also increased by 30%. Conclusion The quality and the yield of lyophilized human fibrinogen were improved using the improved process.
出处 《中国输血杂志》 CAS 北大核心 2016年第9期904-906,共3页 Chinese Journal of Blood Transfusion
关键词 冻干人纤维蛋白原 病毒灭活 乙醇 超滤 lyophilized fibrinogen virus inactivation ethanol uhrafihration
  • 相关文献

参考文献3

二级参考文献12

  • 1王振义 李家增 等.血栓与止血基础理论与临床(第2版)[M].上海:上海科学技术出版社,1995.525.
  • 2Xu W, Chung DW, Davie EW. The assembly of human fibrinogen. The role of the amino-terminal and coiled-coil regions of the three chains in the formation of the alphagamma and betagamma heterodimers and alphabetagamma half-molecules. J Biol Chem, 1996, 271(
  • 3Okumura N, Terasawa F, Tanaka H, et al. Analysis of fibrinogen gamma-chain truncations shows the C-terminus,particularly gammaIle387,is essential for assembly and secretion of this multichain protein. Blood, 2002, 99(10): 3654-3660.
  • 4van′-t-Hooft FM, von-Bahr SJ, Silveira A, et al. Two common,functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration. Arterioscler Thromb Vasc Biol, 1999, 19(12): 3063-3070.
  • 5Brown ET, Fuller GM. Detection of a complex that associates with the Bbeta fibrinogen G-455-A polymorphism. Blood, 1998, 92(9): 3286-3293.
  • 6Iacoviello L, Vischetti M, Zito F, et al. Genes encoding fibrinogen and cardiovascular risk. Hypertension, 2001, 38(5): 1199-1203.
  • 7Vu D, Bolton-Maggs PH, Parr JR, et al. Congenital afibrinogenemia: identification and expression of a missense mutation in FGB impairing fibrinogen secretion. Blood, 2003, 102(13): 4413-4415.
  • 8Duga S, Asselta R, Santagostino E, et al. Missense mutations in the human beta fibrinogen gene cause congenital afibrinogenemia by impairing fibrinogen secretion. Blood, 2000, 95(4): 1336-13341.
  • 9Brummel KE, Butenas S, Mann KG. An integrated study of fibrinogen during blood coagulation. J Biol Chem, 1999, 274(32): 22862-22870.
  • 10Brummel KE, Butenas S, Mann KG. An integrated study of fibrinogen during blood coagulation.J Biol Chem,1999,274(32): 22862-22870.

共引文献47

同被引文献59

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部